Breast Cancer: Challenges and Opportunity

  • 0
  • 3011
Font size:
Print

Breast Cancer: Challenges and Opportunity

Context:

Breast cancer is now the most common cancer among Indian women, previously the fourth most common in the 1990s. Every four minutes, a woman is diagnosed with breast cancer in India, highlighting the increasing prevalence.

More on News

  • Over the next 10 years, 50,000 additional women per year are expected to require treatment.
  • The financial burden is substantial, with an estimated yearly cost of US$19.55 billion.

Contributing and Risk Factors 

  • Gender: 99% of cases occur in women, and 0.5–1% in men. About 50% of women diagnosed have no identifiable risk factors other than being female and over 40 years old.
  • Other Risk Factors: Increasing age, obesity, alcohol use, family history, radiation exposure, reproductive history, tobacco use, and postmenopausal hormone therapy.
    • Women in India are diagnosed at younger ages compared to Western countries, which makes the disease more aggressive in younger women with higher risks of relapse and metastasis.
  • Genetic Factors: Mutations in BRCA1, BRCA2, and PALB-2 genes increase the risk significantly. Women with these mutations may opt for preventive measures like mastectomy or chemoprevention.

Statistics in India (2019-2023)

  • The number of breast cancer cases increased from 200,218 in 2019 to 221,579 in 2023.
  • Deaths from breast cancer increased from 74,481 in 2019 to 82,429 in 2023.
  • Mortality rates are rising, suggesting issues with early detection, treatment access, and management.

Challenges in Breast Cancer Management in India

  • Late Diagnosis and Low Awareness: 60% of cases are detected at stages III or IV.
    • NFHS (2019-2021) data: Only 0.9% of women (30-49 years old) have undergone screening.
    • Lack of awareness about symptoms and the importance of regular screenings. Cultural taboos and social stigma discourage early medical intervention.
  • Inadequate Screening Infrastructure: Limited availability of mammography facilities, particularly in rural areas. High breast density in Indian women affects mammography sensitivity, leading to misdiagnoses. Shortage of trained healthcare professionals and diagnostic centres.
  • Financial Barriers to Treatment: Treatment costs range from INR 100,000 to INR 1,000,000 or more. High out-of-pocket expenses and inadequate insurance coverage lead to high dropout rates.
    • 95% of advanced cancer treatment facilities are located in metropolitan areas, leaving rural populations underserved. India has only 2,000 oncologists for 10 million patients.
  • Psychological Impact on Patients: Breast cancer diagnosis triggers anxiety, depression, fear, and grief. Disruptions to daily life, financial stress, and family burden further affect mental well-being.

Opportunities for Improvement

  • Awareness Campaigns and Public Health Initiatives: Campaigns like “Pink Month” help spread awareness and encourage screenings. School and workplace awareness programs can educate women early. Government and NGO collaborations for community outreach initiatives.
  • Expanding Medical Training and Infrastructure: International School of Oncoplasty (ISOS) & University of East Anglia (UEA) partnership to enhance breast cancer management training in India.
    • Fellowship programs to improve surgical outcomes and encourage breast conservation.
  • Advancements in AI and Technology: AI-driven diagnostic tools like “MammoAssist” enhance mammography accuracy. AI helps detect patterns in MRI scans, ultrasounds, and mammograms, improving early diagnosis.
  • Grassroots Healthcare Programs: Breast Health Initiative (BHI) trains community health workers (ASHAs) and auxiliary nurses to conduct clinical breast examinations. Improves early detection, especially in rural and underserved regions.
  • Policy and Healthcare Reforms: Implementation of comprehensive national cancer care policies to ensure equitable access. Increased investment in screening infrastructure, trained personnel, and advanced treatment technologies.

WHO Response

  • Global Breast Cancer Initiative (GBCI): Aim to reduce global breast cancer mortality by 2.5% annually, preventing 2.5 million deaths from 2020-2040. By 2030, the initiative hopes to prevent 25% of breast cancer deaths, and by 2040, 40% among women under 70.
  • Key Pillars:
    • Health Promotion: Public education on early detection and awareness of symptoms.
    • Timely Diagnosis: Encouraging early consultations even without mammographic screening.
    • Comprehensive Management: Improving access to treatment in resource-limited settings.

What is Breast Cancer?

  • Breast cancer occurs when abnormal breast cells grow uncontrollably, forming tumours. If untreated, these tumours can spread and become fatal.
  • Types: Cancer typically starts in the milk ducts or milk-producing lobules of the breast. Early-stage (in situ) cancer is not life-threatening, but invasive cancer can spread to nearby tissues or lymph nodes, leading to metastasis.
  • Symptoms: Advanced breast cancer can include:
    • Breast lump or thickening
    • Change in size, shape, or appearance of the breast
    • Skin changes (dimpling, redness, pitting)
    • Nipple changes (appearance, fluid discharge)
    • Breast cancer can spread to nearby lymph nodes and organs like the lungs, liver, brain, and bones, causing symptoms like bone pain or headaches.
  • Treatment Options:
  • Surgical Treatment: Lumpectomy (removal of the cancerous tissue) or mastectomy (removal of the whole breast). Lymph nodes may be removed to check for spread.
  • Radiation Therapy: To reduce recurrence risk and treat residual cancer cells.
  • Medications: Hormonal therapies (e.g., tamoxifen, aromatase inhibitors) for hormone receptor-positive cancers.
    • Chemotherapy for hormone receptor-negative cancers and advanced stages.
    • Targeted biological therapies (e.g., trastuzumab) for HER-2 positive cancers.
  • Sentinel Node Biopsy: Preferred over full axillary dissection to check cancer spread with fewer complications.
  • Effectiveness: Early and complete treatment is crucial for better outcomes.

Share:
Print
Apply What You've Learned.
Previous Post Baltic States Switch Electricity Grid from Russia to EU
Next Post Bombay Blood Group
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x